Ironwood Pharmaceuticals
IRWD
IRWD
164 hedge funds and large institutions have $1.49B invested in Ironwood Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 61 increasing their positions, 36 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
7.38% more ownership
Funds ownership: 103.66% → 111.03% (+7.4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
15% less capital invested
Capital invested by funds: $1.76B → $1.49B (-$273M)
Holders
164
Holding in Top 10
3
Calls
$7.83M
Puts
$5.96M
Top Buyers
| 1 | +$48.1M | |
| 2 | +$12.9M | |
| 3 | +$11.9M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.78M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$8.8M |
Top Sellers
| 1 | -$20.7M | |
| 2 | -$13.5M | |
| 3 | -$5.75M | |
| 4 |
HM
HealthCor Management
New York
|
-$5.47M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
-$4.75M |